Dr Pier Amendola
Dr Pier Amendola
PhD – Scientific Advisor, Dravya Discovery

Dr. Pier Giorgio Amendola is a translational scientist and R&D leader with 15+ years of experience across biotechnology and pharmaceutical research. He currently works as an independent advisor supporting pharma and biotech teams, CROs, and investors on preclinical strategy, translational packages, and R&D decision-making. He has previously held senior R&D leadership roles at ONA Therapeutics and Dompé Farmaceutici, leading multidisciplinary teams advancing preclinical programs in oncology, immunology, and ophthalmology.
Dr. Amendola has guided target validation and progressed therapeutic candidates from early research through preclinical development. His expertise spans molecular and cellular biology, advanced human-relevant in vitro disease models, biomarker development, and translational pharmacology, with specific experience in ophthalmology across both anterior and posterior segment indications.
At Dravya Discovery, he provides scientific oversight on pipeline development, experimental planning, and translational positioning, supporting the delivery of differentiated programs toward clinical impact.